Press Releases
Latest investment focuses on empowering employers to improve their data capabilities – unlocking opportunities to better measure the value of their health care benefits and drive towards improved patient outcomes.
Washington, D.C.
December 03, 2024
Morgan Health, a JPMorganChase (NYSE: JPM) business unit made a strategic investment in Merative, a leading data, analytics and technology provider. The Ann Arbor, MI-based company currently serves 40 percent of Fortune 100 employers and has been committed to helping them improve health care decision-making to drive improved performance and quality for the past four decades.
Data provides the foundation needed to empower employers to offer high-quality benefits. In fact, a recent survey of self-insured employers sponsored by Morgan Health revealed that the lack of comprehensive data remains a top challenge when developing an internal health quality strategy. Employers report that compiling medical claims across multiple sources is a challenge – making it difficult to identify differences in quality and unlock areas for improvement. Data is also necessary for training AI models to drive improvements in health care.
“For years, employers have increased their spending on health care without commensurate improvements to the quality of care. Actionable data can improve patient outcomes by helping employers target the right innovations and interventions,” said Dan Mendelson, CEO of Morgan Health. “It’s critically important to put scalable, customizable solutions into employers’ hands to empower them to be more sophisticated purchasers of health care and make more precise decisions regarding the needs of their populations.”
With limited visibility into their own data and a wide array of data solutions to navigate — from storage to analytics — employers often face a patchwork of disparate tools that do not move the needle on improving the health care experience for employees. Given this dynamic, data remains a major impediment for employers today. Merative’s solutions are differentiated in their ability to offer a more comprehensive, integrated view of health care quality and cost.
In addition to its capital, Morgan Health will lend its technical expertise and deep insights into employers’ evolving needs to support the growth and expansion of Merative’s employer-focused platform, Truven. This platform includes Merative’s primary employer and payer analytics product, Health Insights, which offers employers a comprehensive health care analytics solution to help analyze, visualize and report on benefits program performance. It also includes MarketScan databases, which provide a unique source of real world claims data and insights for evidence studies. The dataset is derived from more than 450 suppliers, including employers, health plans, and state Medicaid agencies, offering a comprehensive view to broadly understand healthcare trends for U.S. patients.
This platform strategically supports Morgan Health’s commitment to helping employers implement solutions that guide patients towards high quality and cost-effective insurance products. Additionally, Merative is JPMorganChase’s current vendor for health care claims data storage and analytics. Morgan Health and the JPMorganChase benefits team will partner with Merative to identify opportunities to enhance Merative’s health care data infrastructure and support their evolving needs.
“Merative is excited to partner with Morgan Health and build on our momentum,” said Gerry McCarthy, CEO of Merative. “While this investment will help across all of our business lines, Morgan Health’s expertise in employer-sponsored healthcare will accelerate the value that Truven data and analytics can deliver to employers.”
Since launching in 2021, Morgan Health has been partnering closely with the JPMorganChase benefits team to identify opportunities to optimize data. Recognizing that most employers do not have the capacity to build their own internal data platforms, Morgan Health turned to existing investment opportunities that showed promise in scaling data accessibility across the employer ecosystem.
“Data plays a critical role in managing a self-insured medical plan, from identifying cost trend drivers to understanding condition prevalence,” said Dotan Ziv, Managing Director, Head of U.S. Benefits Design and Strategy at JPMorganChase. “This investment represents JPMorganChase’s continued commitment to helping advance the use of evidence-based strategies and to measure the effectiveness of programs and innovations.”
Morgan Health’s investment will further enable Merative’s scaled innovation for employers’ data needs. Merative will also continue to deliver industry-leading solutions – Cúram, Merge, Micromedex and Zelta – across the care continuum. Francisco Partners, a leading global investment firm that specializes in technology businesses, remains the majority investor in Merative.
Morgan Health is a JPMorganChase business unit focused on improving employer-sponsored health care. Through its investments and the advancement of accountable care, Morgan Health is working to improve the quality, equity and affordability of employer-sponsored health care for JPMorgan Chase employees, their families and the U.S. health system. The business is led by Dan Mendelson, CEO of Morgan Health, reporting to Peter Scher, Vice Chairman of JPMorganChase. Morgan Health is headquartered in Washington, D.C. Visit morganhealth.com.
Merative provides data, analytics, and software for healthcare and government social services. With focused innovation and deep expertise, Merative works with providers, employers, health plans, governments, and life sciences companies to improve decision-making and performance. Learn more at merative.com.
Francisco Partners is a leading global investment firm that specializes in partnering with technology and technology-enabled businesses. Since its launch 25 years ago, Francisco Partners has invested in over 450 technology companies, making it one of the most active and longstanding investors in the technology industry. With approximately $45 billion in capital raised to date, the firm invests in opportunities where its deep sectoral knowledge and operational expertise can help companies realize their full potential. For more information on Francisco Partners, visit franciscopartners.com.
